Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02563574 · ClinicalTrials.gov registry record · NA

ARCH II Study (Alcohol Research Center on HIV Study II)

A NA study of HIV and Alcohol Consumption, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
14
Enrollment target
2
Study locations

NCT02563574 is a NA study of HIV and Alcohol Consumption that has completed, run by University of Florida. The registered enrollment target is 14 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02563574, a NA study of HIV and Alcohol Consumption, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
2
Study locations

Study Summary

This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives. The first is to incorporate functional neuroimaging (FMRI) approaches, along with additional Magnetic Resonance Spectroscopy (MRS) methods that will enable a delineation in both functional and cerebral metabolic disturbances affecting specific functional brain systems that are associated with the interaction of ethanol (ETOH) consumption on Human Immunodeficiency Virus (HIV)-associated brain dysfunction. Recent data indicate that HIV infected patients with heavy ETOH consumption have FMRI abnormalities and exhibit alterations on other neuroimaging measures compared to moderate drinkers and people who do not drink at all. The second objective is to examine the extent to which reductions in ETOH consumption among heavy drinkers with HIV infection result from a motivational intervention. The findings from this study will provide important information on how heavy ETOH and HIV interact to affect the brain functional responsiveness, and the extent of improvement that might be gained by reducing heavy ETOH use.

Conditions Studied

HIV Alcohol Consumption Motivation

Interventions

  • BEHAVIORAL Motivational Interviewing
  • OTHER Blood specimens
  • OTHER Questionnaire assessment
  • OTHER Neurocognitive assessments

Study Locations (2)

Florida

  • University of Florida - Gainesville
  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2016-12
Est. Completion 2021-12-16
Phase NA

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02563574

The ClinicalTrials.gov registry entry for NCT02563574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 4 interventions - of which Motivational Interviewing is the first listed.

NCT02563574 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02563574 about?

NCT02563574 is a clinical study titled "ARCH II Study (Alcohol Research Center on HIV Study II)". This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives. The first is to incorporate functional neuroimaging (FMRI) approaches, along with additional Magnetic Resonance Spectroscopy (MRS) methods that...

What is the current status of trial NCT02563574?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-12. Estimated completion is 2021-12-16.

What conditions does trial NCT02563574 study?

This clinical trial studies the following conditions: HIV, Alcohol Consumption, Motivation.

What interventions are being tested in trial NCT02563574?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Blood specimens (OTHER), Questionnaire assessment (OTHER), Neurocognitive assessments (OTHER).

Who is sponsoring clinical trial NCT02563574?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02563574 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV

All registered trials for this condition

Alcohol Consumption

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.